ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
13 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: Lupus Foundation of America 2014 Career Development Award
Application Deadline: March 28, 2014 at 5 p.m. ET
To facilitate the professional development of heumatology, nephrology, and dermatology fellows, in the U.S. and Canada, interested in lupus research to wards a career as an independent clinician-scientist at an academic, medical, or research institution, with a research program having considerable focus on the investigation of basic, clinical, translational, behavioral, or epidemiological lupus research.
Award Amount: $70,000 per year (for a maximum of 2 years)
To be eligible to apply, applicants must hold an M.D. (or equivalent) from an accredited institution, be a U.S. citizen or legal resident of the U.S.or Canada at the time of application submission, be a first or second year Fellow
in an adult or pediatric fellowship program in rheumatology, nephrology, or dermatology accredited by either the American Council on Graduate Medical Education (in the U.S.) or Royal College of Physicians and Surgeons (in Canada). In addition, to be eligible, applicants must have a documented history of conducting lupus research or must have submitted a lupus-specific abstract to the American College of Rheumatology or similar scientific meeting (or plan to do so) during the fellowship period.
Applicants who currently or previously have been awarded any of the following grant awards are ineligible to apply:
a mentored award (such as a K award) or NIH research grant (such as an RO1, RO3, R21, PO1, P50, or any similar award), VA Career Development Award, American College of Rheumatology (ACR) REF Rheumatology Scientist Development Award, ACR REF Rheumatology Investigator Award, ACR REF Career Development Bridge Funding Award, or Arthritis Foundation Clinical to Research Transition Award.
The LFA Career Development Award will provide 1 or 2 grant awards in the amount of $70,000 each The fellowship funding may be renewable for a second year of an additional $70,000 depending upon progress (including a consideration about whether a lupus-specific abstract has or will be submitted).
National Ataxia Foundation Pioneer SCA Translational Research Award
One-year grant of $100,000 focusing on research investigations that will facilitate the development of treatments for the Spinocerebellar Ataxias (SCAs) will be awarded.
August 15, 2014 - Date the Letter of Intent is due with a ½ to one-page abstract with specific aims of your research.
September 15, 2014 - Full application due
Email all correspondence and questions to Sue Hagen at firstname.lastname@example.org. Please include the last name of the principal investigator as the first word in the subject line of any email you send.
Call for Applications: Alex's Lemonade Stand Foundation Reach Awards
Alex's Lemonade Stand Foundation (ALSF) evolved from the front yard lemonade stand of cancer patient Alexandra “Alex” Scott (1996-2004) into a national fundraising movement to raise awareness and find cures for all childhood cancers.
Reach Awards are designed to move hypothesis-driven research toward the clinic. A successful application will identify an unmet clinical need relevant to the care of patients with pediatric cancer and describe how the work performed will allow for the translation of hypothesis-driven research to the clinic keeping broader clinical testing and implementation in view.
All Reach Award applications must be received by May 30, 2014 - 11:59 PM ET.
Maximum of $250,000 in total costs awarded over two years.
All applications must be submitted using ALSF’s online submission process.
The purpose of the Reach Award is to advance ALSF’s mission to find cures and better treatments for childhood cancers by providing support to move hypothesis-driven research into the clinic. Significant barriers exist that impede the translation of innovative and important ideas to the clinic. The Reach Award seeks to remove one of these barriers by providing support for important pre-clinical projects that are necessary to move a study from the pre-clinical arena into a clinical trial. Thus, the goal of this award is to support selected “late translational” studies needed to ultimately initiate a clinical trial. Preference will be given to those research projects which, if funded, will result in the initiation of a clinical trial within two to three years.
Primary applicants may be Assistant, Associate or Professor level investigators who demonstrate a track record of discovery, investigation and external funding. Applicants may be M.D., D.O., Ph.D, or M.D./Ph.D. Applicants must have a demonstrated track record of pediatric cancer research with experience in translational research Multiple investigator applications that bring together pairs or teams of researchers with complementary expertise are encouraged. Phase I/II Trials are not eligible for funding by this grant mechanism.
Call for Proposals: Academy of Neurologic Communication Disorders and Sciences Collaborative Clinical Research Grant
Deadline for receipt of grant applications: No later than 5:00 p.m. EST Monday, April 14, 2014.
The primary purpose of the Academy of Neurologic Communication Disorders and Sciences Collaborative Clinical Research Grant (ANCDS-CCRG) award is to encourage collaborative research between two ANCDS members from two different institutions by providing $5,000 to meritorious scientific proposals addressing a clinical research question. The Dean or other signatory authority of both collaborating universities/institutions is encouraged to match the grant from ANCDS ($5,000) with at least $2,500 up to $5,000 each so that the collaborative awardees may receive a total of $10,000 to $15,000 to accomplish their research aims. While a contribution of $5,000 each is preferred, applications with guaranteed institutional support for less than this amount will be considered.
Priorities. The successful proposal will:
1. Focus on an innovative and significant clinical research question.
2. Address translational, outcomes, effectiveness, or comparative effectiveness research.
3. Position collaborative ANCDS clinical scholars to seek larger extramural grants.
Call for Applications: American Gastroenterological Association Microbiome Junior Investigator Research Award
Eligibility: Applicants who completed clinical training or received their final research degree in 2007 or later.
Duration: Two years
Deadline: June 6, 2014
Start Date: Oct. 1, 2014
This award provides $30,000 per year for up to two years to junior investigators engaged in research related to the gut microbiome. Supported research may include basic, translational, clinical or health services investigation.
The overall goal of the AGA research awards program is to enable investigators, especially those in the early stages of their careers, to develop and maintain independent and productive research programs in digestive diseases.
The specific objective of this award is to encourage and facilitate innovative research into relationships between the gut microbiome and functioning of the digestive system in health and disease.
• Applicants for this award must hold an MD, PhD or equivalent degree (e.g., MB, ChB, MBBS or DO) and a full-time faculty position at a North American educational institution as of June 1, 2014.
• Applicants must be in the early phase of their careers: clinicians who completed clinical training and investigators who received their final research degree no more than seven (7) years before the application due date.
• Preference will be given to applicants who have not previously received R01 or similar major research awards from the NIH or other funding agencies but recipients of such awards are eligible for funding under this mechanism.
• The length of appropriately documented parental leave(s) of absence will not count toward the seven-year eligibility criterion. Exceptional circumstances may also be considered.
• Women and members of underrepresented minorities are strongly encouraged to apply.
• Recipients of this award must be full members of the AGA. Applicants who are not AGA members at the time of application must apply for and be accepted as members before funding will be released.
• Institutional indirect (facilities and administration) costs are not allowed. Upon notification of selection for this award, the principal investigator must submit documentation of approval from the appropriate institutional committee(s) for use of human subjects and/or animals. If such approval is not necessary, the recipient must submit a written explanation.
• The principal investigator must submit a scientific progress report and the recipient institution must submit a financial statement by January 31, 2015. Second year funding is contingent upon submission and review of this documentation. Within 60 days of completion or other termination of this award, a concise summary of the results of the research that it supported must be submitted to the AGA Research Foundation.
• All publications, presentations and abstracts arising from work supported by this award must acknowledge support of the AGA Microbiome Junior Investigator Research Award.
• It is expected that a manuscript describing studies performed under this award will be submitted to Gastroenterology or Clinical Gastroenterology and Hepatology.
• The recipient of this award will be recognized at the Researcher Recognition Celebration during DDW. The recipient and his/her sponsor will be expected to attend.
There must be a strong commitment from the candidate’s institution, ensuring that the applicant has adequate protected time, research space, and other supporting facilities and resources to enable successful completion of the proposed research. This commitment must be outlined in a letter from the candidate’s division chief or department chair. The letter must certify the amount of protected time and the nature of other resources that will be available to the applicant upon receipt of the award.
The recipient will be selected based on the following criteria:
• significance of the proposed research and implication for preventing or treating disease.
• scientific approach.
• institutional environment and support.
• applicant potential and commitment.
Members of the AGA Institute Research Awards Panel will review all submitted proposals and select the award recipient. Funding will begin on Oct. 1, 2014.
The application deadline is June 6, 2014. The completed application, letters of support and commitment and other documents must be combined and submitted as a single PDF document. The title of the document must include only the applicant’s last name and first initial and be sent by email to email@example.com. Hard copies will not be accepted.
Please direct all questions to the senior research awards manager at 301-222-4012 or firstname.lastname@example.org.
Funding for the AGA Microbiome Junior Investigator Award has been provided through a grant from Danone to the AGA Institute.
Call for Nominations: American Diabetes Association Pathway Awards
Application deadline: July 1, 2014
Pathway supports innovative basic, clinical, translational, epidemiological, behavioral, or health services research relevant to any diabetes type, diabetes-related disease state, or diabetes complication. The Association seeks exceptional candidates from a broad range of disciplines, including medicine, biology, chemistry, computing, physics, mathematics and engineering.
The prestigious Pathway awards are available by institutional nomination only.
Lung Cancer Research Foundation Grant Program
Deadline: Friday, June 16, 2014
The Lung Cancer Research Foundation's grant program provides critical seed support for cutting-edge scientific research on all cancers of the lung. We believe this type of support can build proof of concept for researchers to apply for additional grant funding from universities and public sources.
LCRF GRANTS ARE AWARDED FOR LUNG CANCER PROJECTS FOCUSED ON:
• Basic Science
• Translational Research
• Clinical Research
• Supportive Care
• Quality of Care/Outcomes
LCRF PROVIDES FUNDS TO U.S. AND INTERNATIONAL INVESTIGATORS FROM NOT FOR PROFIT INSTITUTIONS:
• Graduate students
• Post-doctoral researchers
• Medical students
• Nurse researchers
Myocarditis Foundation Research Grants
The Myocarditis Foundation is currently accepting applications for Research Grants.
Types of Proposals Sought
The Myocarditis Foundation (MF) accepts fellowship grant applications on an annual basis for innovative basic, clinical or translational research relevant to the cause or treatment of myocarditis. MF’s fellowship grant program is designed to provide seed funding to investigators for the testing of initial hypotheses and collecting preliminary data to help secure long-term funding by the National Institute of Health (NIH) and other major granting institutions. Funding is available at US $35,000 for salary only.
Grant award decisions are made through a peer review process by our Medical Advisory Board. Scientific excellence and relevance to myocarditis are the basic criteria for selecting the supported research project. The award is designed to support training and career development of physician-scientists in myocarditis research.
The MF research grant provides salary support for 1 year of full-time research. The stipend is $35,000. No additional funds for benefits, travel, or indirect costs, etc. are available.
Candidates may apply up to 10 years following receipt of an MD, PhD, or an equivalent degree and plan to perform the funded work in the United States or Canada, in order to apply for the Fellowship. All applicants must select a preceptor with a proven track record of research in myocarditis. In addition to providing a letter of recommendation, the preceptor is expected to assist in preparing the application. For applicants wishing advice in the selection of a preceptor, a list of potential preceptors is available from the MF.
The MF will issue a request for proposals in September of each year. The deadline for grant submission is December 15th with final award decisions made by December 31st. The research plan should be limited to 5 pages and must include the following: hypothesis, specific aims, background/significance, preliminary data, methods and expected results. The applicant should include a cover letter, supporting letter from the preceptor, and applicant and preceptor biographical sketches. Upon receipt of a signed letter of agreement from the selected candidate the MF will disburse the funds in installments during the research year.
A final report will be required upon completion of the research year. The Myocarditis Foundation reserves the right to cite the research in all/any of our printed materials and on our website. The Myocarditis Foundation must be acknowledged in all publications resulting from the research.
North American Neuroendocrine Tumor Society Young Investigator Award
Deadline for submission of the application is June 30, 2014 (11:59 pm PDT).
The purpose of the NANETS Young Investigator Award is to encourage investigators at the end of their fellowship or beginning of their faculty appointment to pursue basic and/or translational research focused on neuroendocrine tumors.
Award Term: The NANETS Young Investigator Award will provide $50,000 per year for one year. Award funds will be directed to the sponsoring institution. At the conclusion of the award period, the recipient must provide NANETS with a written progress report of research performed during the award period and a budget reconciliation.
• Candidates must have a MD, MD/PhD, PhD, DO degree or equivalent
• Candidates must be in the first 5 years of a faculty appointment (instructor, research scientist or above) in an accredited medical school or other institution in North America
• Candidates must be a NANETS member
Selection Criteria: Criteria for selection will include both the research proposal itself and the potential of the individual to make future scientific and/or clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements, as well as the research proposal. The research proposals section should focus on research projects with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) studies of neuroendocrine tumor epidemiology, risk factors, clinical outcomes, novel treatment strategies, and translational research projects with clear clinical significance. The research proposal can include development of a clinical trial and/or correlative studies involving existing clinical trials.
Friedreich's Ataxia Research Alliance Phillip Bennett and Kyle Bryant Translational Research Award
FARA accepts LOIs focusing on pre-clinical and clinical investigations that will advance treatments for FA.
The specific aims must target one or more of the following:
Identification of biomarkers for FA that will elucidate disease variability, severity, and prognosis; facilitate drug screening, and/or optimize selection of patients and clinical endpoints for clinical trials;
Development of tools and technologies that can (a) be directly used for therapy development; (b) overcome existing obstacles to treatment and (c) be directly applied to, or adapted for, delivery of potential therapeutics;
Pre-clinical development and testing of potential therapeutics, biologics, and devices in cells and animals;
Clinical studies of patient outcome measures, potential interventions, or devices.
The deadline for the LOI is May 15. For those invited to submit a full application, the deadline for submission is July 15. On the Main Grant Page, put “PB and KB Translational Award” in the “Grant Type” field. The applicant may request a budget of up to $250,000 per year for one or two years.